Rhenman & Partners Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Rhenman & Partners Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell
2015 Q1	$3.01M	Hold
2014 Q4	$2.08M	Hold
2014 Q3	$1.83M	Sell
2014 Q2	$2.62M	Buy
2014 Q1	$2.66M	Buy
2013 Q4	$2M	Buy